(Q40957716)

25 September 2017

Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancer (English)

1 reference

25 September 2017

0 references

Chun Chieh Lin

1

1 reference

25 September 2017

Phillip J Gray

series ordinal

2

1 reference

25 September 2017

Ahmedin Jemal

series ordinal

3

1 reference

25 September 2017

Jason A Efstathiou

series ordinal

4

1 reference

25 September 2017

language of work or name

English

0 references

publication date

9 May 2015

1 reference

Journal of the National Cancer Institute

25 September 2017

1 reference

25 September 2017

107

1 reference

25 September 2017

7

1 reference

EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.

25 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Comparison of cases captured in the national cancer data base with those in population-based central cancer registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

The national cancer data base: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Comparison of commission on cancer-approved and -nonapproved hospitals in the United States: implications for studies that use the National Cancer Data Base

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Regional variation in quality of prostate cancer care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Income inequality and treatment of African American men with high-risk prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

Racial/ethnic disparities in the treatment of localized/regional prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJV119

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJV119

1 reference

25 September 2017

1 reference